A New Model of Epidermal Culture for the Surgical Treatment of Vitiligo
Overview
Affiliations
Background: Vitiligo can be successfully treated with grafts of autologous cultured epidermal cells.
Objective: To evaluate the efficacy of autologous grafting of epidermal cells, cultured by an original method, in the treatment of localized vitiligo refractory to other therapies.
Methods: Autologous normally pigmented skin was used to culture keratinocytes and melanocytes on a supporting layer of biomaterial (Laserskin), which was grafted directly onto achromatic skin after de-epithelialization with liquid carbon dioxide. The percentage area of repigmentation was calculated by image analysis.
Results: Initial repigmentation of the treated areas was observed 1 month after treatment. Repigmentation continued to increase for 3 months after grafting. Follow-up at 3, 6, 12, and 18 months showed almost complete repigmentation in six out of 11 cases. In four other patients, 40-71% of the grafted achromatic area was repigmented. In one patient, repigmentation was impeded by sepsis.
Conclusions: The method was found to be effective in the treatment of localized vitiligo refractory to other treatments. The therapeutic procedure was simple, reproducible, and easy to use.
Wound Healing: Biologics, Skin Substitutes, Biomembranes and Scaffolds.
Vyas K, Vasconez H Healthcare (Basel). 2016; 2(3):356-400.
PMID: 27429283 PMC: 4934597. DOI: 10.3390/healthcare2030356.
Stem Cells in Skin Regeneration, Wound Healing, and Their Clinical Applications.
Ojeh N, Pastar I, Tomic-Canic M, Stojadinovic O Int J Mol Sci. 2015; 16(10):25476-501.
PMID: 26512657 PMC: 4632811. DOI: 10.3390/ijms161025476.
Petrof G, Abdul-Wahab A, McGrath J Cold Spring Harb Perspect Med. 2014; 4(6).
PMID: 24890834 PMC: 4031958. DOI: 10.1101/cshperspect.a015156.
Amniotic membrane as a scaffold for melanocyte transplantation in patients with stable vitiligo.
Redondo P, Gimenez de Azcarate A, Marques L, Garcia-Guzman M, Andreu E, Prosper F Dermatol Res Pract. 2011; 2011:532139.
PMID: 21869882 PMC: 3159018. DOI: 10.1155/2011/532139.
Current and emerging therapy for the management of vitiligo.
Bordere A, Lambert J, van Geel N Clin Cosmet Investig Dermatol. 2011; 2:15-25.
PMID: 21436965 PMC: 3047938.